Asymptomatic IgE sensitization to Hymenoptera venom (HV)

#LargeLocalReactions (LLRs) at the #Hymenoptera sting site

👉Biomarkers for the Molecular Diagnosis of IgE-Mediated #Hymenoptera #Venom #Allergy in Clinical Practice [Popescu FD, Preda M, Antolín-Amérigo D, Rodríguez-Otero N, Ramírez-Mateo E, Smolinska https://t.co/qIFLqyrVTV J Mol Sci. 2024 Dec 31;26(1):270] https://t.co/EOQdk4FOrL

The future of allergy and clinical immunology lies in the next generation. This article highlights the increasing impact of JMs in EAACI, their contributions, and exciting opportunities ahead. Full article here: https://t.co/9wG0yeZGU9 #EAACI #JuniorMembers #Allergy #Immunology

Today is World Atopic Eczema Day! Together, let’s raise awareness, encourage early care, and show support for every child and family living with eczema. #WorldAtopicEczemaDay #EczemaAwareness #PaediatricAllergy

🗣️Prof. Jolanta Walusiak-Skorupa: kampania ma szczególne znaczenie również w środowisku zawodowym. Zdrowi pracownicy to stabilne firmy i bezpieczne miejsca pracy. Szczepienia to inwestycja zarówno w ochronę zdrowia, jak i w gospodarkę. #szczepienia

Real-world step-down dupilumab dosing shows positive results for eosinophilic esophagitis—potential for more patient-friendly treatment plans! #EoE #Dupilumab @EAACI_HQ @EAACI_JM @eaaci @pai_eaaci @worldallergy @BSACI_Allergy @bbchealth https://t.co/fa6nTJyJo4

New transcriptomics findings map cytokine and receptor profiles in blood eosinophils—unlocking clues for tailored immune interventions. #Eosinophils #Immunology @BSACI_Allergy @EAACI_HQ @EAACI_JM @worldallergy https://t.co/Xg7Cb4VhMa

Danish data: Comorbid atopic dermatitis steers first-line dupilumab use in severe asthma based on key biomarkers. Personalized approaches are shaping the field! #SevereAsthma #Dupilumab #Biologics @EAACI_HQ @EAACI_JM @eaaci @pai_eaaci @worldallergy https://t.co/zI7y4kiyp8

Allergic rhinitis rates have surged across China in the last 20 years—driven by urban life, pollution, and shifting habits. Spotlight on the need for better screening and tailored interventions! #Allergy #China @worldallergy @EAACI_HQ @EAACI_JM @pai_eaaci https://t.co/uJaTVRwe8b

Research reveals benralizumab’s unique impact on airway and sinus inflammation in severe asthma patients with nasal polyps, bringing promise for more precise treatment. #Benralizumab #SevereAsthma @EAACI_HQ @EAACI_JM @BSACI_Allergy @worldallergy https://t.co/jtSw5LR0xM

Study finds environmental and cultural differences influence early childhood eczema rates in Chinese kids from Shanghai and Singapore. Risk factors aren’t the same everywhere! #Eczema #Pediatrics #GlobalHealth @EAACI_HQ @worldallergy @EAACI_JM https://t.co/aA8T7Jqwxo

New analysis shows higher rates of metabolic syndrome in people with chronic urticaria, highlighting the need for broader health checks in these patients. #ChronicUrticaria #MetabolicSyndrome #dermatology @EAACI_HQ @EAACI_JM @worldallergy @BSACI_Allergy https://t.co/qngruuueho

Antibiotic-induced anaphylaxis remains a major health concern—penicillins and beta-lactams top the list for severe reactions. Vigilance and prevention save lives. #Anaphylaxis #Antibiotics #DrugSafety #Pharmacovigilance @EAACI_HQ @EAACI_JM @worldallergy https://t.co/Fbm4ZtBD3Y

Setting the right IgE cut-off for the Cannabis sativa LTP allergen could transform cannabis allergy diagnosis. Precise testing means safer care. #CannabisAllergy #IgE #AllergyTesting #PrecisionMedicine @EAACI_HQ @EAACI_JM @worldallergy @BSACI_Allergy https://t.co/ug6hFaeSVZ

JAK inhibitors deliver real-world relief for moderate-to-severe atopic dermatitis, matching clinical trial success. Acne and lab changes are common but manageable. #AtopicDermatitis #Dermatology @pai_eaaci @EAACI_HQ @EAACI_JM @BSACI_Allergy https://t.co/alS3Bc8CIS

Low-dose peanut OIT in preschoolers safely boosts allergy tolerance, improving quality of life. Parent-led, home-based treatment shows real promise. #PeanutAllergy #OralImmunotherapy #FoodAllergy @EAACI_HQ @worldallergy @BSACI_Allergy @EAACI_JM https://t.co/CMEexfgamU

20% change in FeNO may mark meaningful asthma improvement, but FeNO alone is a limited surrogate. Comprehensive monitoring remains essential. #Asthma #FeNO #ACQ #RespiratoryHealth @pai_eaaci @EAACI_HQ @worldallergy @BSACI_Allergy @bbchealth https://t.co/iC3nlNAM5J

Patients and parents reveal key needs to optimize eosinophilic esophagitis care in Australia—personalized support, education, and improved health services. #EoE #PatientVoices #ChronicDisease #AllergyCare @eaaci @EAACI_HQ @EAACI_JM @worldallergy https://t.co/yAcop3Ea3D

Oscillometry may detect bronchodilator reversibility and small airway disease better than spirometry in severe asthma—offering an easier, accurate diagnostic tool. #Asthma #Oscillometry #Spirometry @pai_eaaci @EAACI_HQ @worldallergy @BSACI_Allergy https://t.co/dNgX06LYUD